AAAAAA
Results:
1-22
|
Results: 22
Authors:
Beerlage, HP
Aarnink, RG
Ruijter, ET
Witjes, JA
Wijkstra, H
van de Kaa, CA
Debruyne, FMJ
de la Rosette, JJMCH
Citation: Hp. Beerlage et al., Correlation of transrectal ultrasound, computer analysis of transrectal ultrasound and histopathology of radical prostatectomy specimen, PROSTATE C, 4(1), 2001, pp. 56-62
Authors:
Oyen, WJG
Witjes, JA
Corstens, FHM
Citation: Wjg. Oyen et al., Nuclear medicine techniques for the diagnosis and therapy of prostate carcinoma, EUR UROL, 40(3), 2001, pp. 294-299
Authors:
Vriesema, JLJ
Atsma, F
Kiemeney, LALM
Peelen, WP
Witjes, JA
Schalken, JA
Citation: Jlj. Vriesema et al., Diagnostic efficacy of the ImmunoCyt test to detect superficial bladder cancer recurrence, UROLOGY, 58(3), 2001, pp. 367-371
Authors:
Spermon, JR
Witjes, JA
Nap, M
Kiemeney, LALM
Citation: Jr. Spermon et al., Cancer incidence in relatives of patients with testicular cancer in the eastern part of the Netherlands, UROLOGY, 57(4), 2001, pp. 747-752
Authors:
Aben, KKH
Macville, MVE
Smeets, DFCM
Schoenberg, MP
Witjes, JA
Kiemeney, LALM
Citation: Kkh. Aben et al., Absence of karyotype abnormalities in patients with familial urothelial cell carcinoma, UROLOGY, 57(2), 2001, pp. 266-269
Authors:
Vriesema, JLJ
Aben, KKH
Witjes, JA
Kiemeney, LALM
Schalken, JA
Citation: Jlj. Vriesema et al., Superficial and metachronous invasive bladder carcinomas are clonally related, INT J CANC, 93(5), 2001, pp. 699-702
Authors:
Witjes, JA
Kiemeney, LALM
Wheeless, LL
Grossman, HB
Citation: Ja. Witjes et al., The value of histopathological prognostic factors in superficial bladder cancer: Do we need more?, UROL ONCOL, 5(5), 2000, pp. 185-190
Authors:
Aben, KKH
Witjes, JA
van Dijck, JAAM
Schalken, JA
Verbeek, ALM
Kiemeney, LALM
Citation: Kkh. Aben et al., Lower incidence of urothelial cell carcinoma due to the concept of a clonal origin, EUR J CANC, 36(18), 2000, pp. 2385-2389
Authors:
Mungan, NA
Vriesema, JLJ
Thomas, CMG
Kiemeney, LALM
Witjes, JA
Citation: Na. Mungan et al., Urinary bladder cancer test: A new urinary tumor marker in the follow-up of superficial bladder cancer, UROLOGY, 56(5), 2000, pp. 787-791
Authors:
Vriesema, JLJ
Poucki, MH
Kiemeney, LALM
Witjes, JA
Citation: Jlj. Vriesema et al., Patient opinion of urinary tests versus flexible urethrocystoscopy in follow-up examination for superficial bladder cancer: A utility analysis, UROLOGY, 56(5), 2000, pp. 793-797
Authors:
van der Poel, HG
Sedelaar, JPM
Debruyne, FMJ
Witjes, JA
Citation: Hg. Van Der Poel et al., Recurrence of germ cell tumor after orchiectomy, UROLOGY, 56(3), 2000, pp. 467-473
Authors:
Witjes, JA
Mungan, NA
Debruyne, FMJ
Citation: Ja. Witjes et al., Management of superficial bladder cancer with intravesical chemotherapy: An update, UROLOGY, 56(1), 2000, pp. 19-21
Authors:
Mungan, NA
Aben, KKH
Schoenberg, MP
Visser, O
Coebergh, JWW
Witjes, JA
Kiemeney, LALM
Citation: Na. Mungan et al., Gender differences in stage-adjusted bladder cancer survival, UROLOGY, 55(6), 2000, pp. 876-880
Authors:
van Rhijn, BWG
van der Poel, HG
Boon, ME
Debruyne, FMJ
Schalken, JA
Witjes, JA
Citation: Bwg. Van Rhijn et al., Presence of carcinoma in situ and high 2c-deviation index are the best predictors of invasive transitional cell carcinoma of the bladder in patients with high-risk Quanticyt, UROLOGY, 55(3), 2000, pp. 363-367
Authors:
Mungan, NA
Kiemeney, LALM
van Dijck, JAAM
van der Poel, HG
Witjes, JA
Citation: Na. Mungan et al., Gender differences in stage distribution of bladder cancer, UROLOGY, 55(3), 2000, pp. 368-371
Authors:
Mungan, NA
Aben, KKH
Beeks, E
Kampman, E
Bunschoten, A
Bussemakers, M
Witjes, JA
Kiemeney, LALM
Citation: Na. Mungan et al., A germline homozygote deletion of the glutathione-S-transferase Mu1 gene predisposes to bladder cancer, UROL INTERN, 64(3), 2000, pp. 134-138
Authors:
Aben, KKH
Cloos, J
Koper, NP
Braakhuis, BJM
Witjes, JA
Kiemeney, LALM
Citation: Kkh. Aben et al., Mutagen sensitivity in patients with familial and non-familial urothelial cell carcinoma, INT J CANC, 88(3), 2000, pp. 493-496
Authors:
Steffens, MG
Boerman, OC
de Mulder, PHM
Oyen, WJG
Buijs, WCAM
Witjes, JA
van den Broek, WJM
Oosterwijk-Wakka, JC
Debruyne, FMJ
Corstens, FHM
Oosterwijk, E
Citation: Mg. Steffens et al., Phase I radioimmunotherapy of metastatic renal cell carcinoma with I-131-labeled chimeric monoclonal antibody G250, CLIN CANC R, 5(10), 1999, pp. 3268S-3274S
Authors:
Barentsz, JO
Engelbrecht, M
Jager, GJ
Witjes, JA
de LaRosette, J
van der Sanden, BP
Huisman, HJ
Heerschap, A
Citation: Jo. Barentsz et al., Fast dynamic gadolinium-enhanced MR imaging of urinary bladder and prostate cancer, J MAGN R I, 10(3), 1999, pp. 295-304
Authors:
Beerlage, HP
van Leenders, GJLH
Oosterhof, GON
Witjes, JA
Ruijter, ET
van de Kaa, CA
Debruyne, FMJ
de la Rosette, JJMCH
Citation: Hp. Beerlage et al., High-intensity focused ultrasound (HIFU) followed after one to two weeks by radical retropubic prostatectomy: Results of a prospective study, PROSTATE, 39(1), 1999, pp. 41-46
Authors:
Mungan, NA
Kulacoglu, S
Basar, M
Sahin, M
Witjes, JA
Citation: Na. Mungan et al., Can sensitivity of voided urinary cytology or bladder wash cytology be improved by the use of different urinary portions?, UROL INTERN, 62(4), 1999, pp. 209-212
Authors:
Steffens, MG
Boerman, OC
Oyen, WJG
Kniest, PHM
Witjes, JA
Oosterhof, GON
van Leenders, GJLH
Debruyne, FMJ
Corstens, FHM
Oosterwijk, E
Citation: Mg. Steffens et al., Intratumoral distribution of two consecutive injections of chimeric antibody G250 in primary renal cell carcinoma: Implications for fractionated doseradioimmunotherapy, CANCER RES, 59(7), 1999, pp. 1615-1619
Risultati:
1-22
|